PortfoliosLab logoPortfoliosLab logo
DNTH vs. LQDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DNTH vs. LQDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dianthus Therapeutics Inc. (DNTH) and Liquidia Corporation (LQDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DNTH achieves a 159.45% return, which is significantly higher than LQDA's 143.87% return.


DNTH

1D
-5.08%
1M
13.33%
6M
100.26%
YTD
159.45%
1Y
419.28%
3Y*
5Y*
10Y*
ALL TIME*
124.41%

LQDA

1D
-3.10%
1M
6.56%
6M
98.42%
YTD
143.87%
1Y
375.74%
3Y*
120.93%
5Y*
105.41%
10Y*
ALL TIME*
26.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$89.59M$95.14M$92.66M
$129.21M$115.99M$136.40M

DNTH vs. LQDA - Yearly Performance Comparison


2026 (YTD)202520242023
DNTH
Dianthus Therapeutics Inc.
159.45%89.04%109.62%0.00%
LQDA
Liquidia Corporation
143.87%193.28%-2.24%70.40%

Correlation

The correlation between DNTH and LQDA is 0.32, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.32

Correlation (All Time)
Calculated using the full available price history since Sep 12, 2023

0.26

Fundamentals

Market Cap

DNTH:

$4.46B

LQDA:

$7.48B

EPS

DNTH:

-$0.45

LQDA:

$0.23

PS Ratio

DNTH:

3.09K

LQDA:

27.98

Total Revenue (TTM)

DNTH:

$873.00K

LQDA:

$288.07M

Gross Profit (TTM)

DNTH:

$873.00K

LQDA:

$275.77M

EBITDA (TTM)

DNTH:

-$187.38M

LQDA:

$51.53M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DNTH vs. LQDA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

DNTH
DNTH Risk / Return Rank: 9999
Overall Rank
DNTH Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
DNTH Sortino Ratio Rank: 9999
Sortino Ratio Rank
DNTH Omega Ratio Rank: 9898
Omega Ratio Rank
DNTH Calmar Ratio Rank: 100100
Calmar Ratio Rank
DNTH Martin Ratio Rank: 100100
Martin Ratio Rank

LQDA
LQDA Risk / Return Rank: 9898
Overall Rank
LQDA Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
LQDA Sortino Ratio Rank: 9898
Sortino Ratio Rank
LQDA Omega Ratio Rank: 9797
Omega Ratio Rank
LQDA Calmar Ratio Rank: 9999
Calmar Ratio Rank
LQDA Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

DNTH vs. LQDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dianthus Therapeutics Inc. (DNTH) and Liquidia Corporation (LQDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DNTHLQDADifference
Sharpe ratioReturn per unit of total volatility

+1.03

Sortino ratioReturn per unit of downside risk

+0.76

Omega ratioGain probability vs. loss probability

1.69

1.56

+0.13

Calmar ratioReturn relative to maximum drawdown

20.83

9.89

+10.94

Martin ratioReturn relative to average drawdown

53.91

25.71

+28.19

DNTH vs. LQDA - Sharpe Ratio Comparison

The current DNTH Sharpe Ratio is 6.33, which is comparable to the LQDA Sharpe Ratio of 5.31. The chart below compares the historical Sharpe Ratios of DNTH and LQDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DNTH vs. LQDA - Drawdown Comparison

The maximum DNTH drawdown since its inception was -53.48%, smaller than the maximum LQDA drawdown of -93.87%. Use the drawdown chart below to compare losses from any high point for DNTH and LQDA.


Loading charts...

Drawdown Indicators


DNTHLQDADifference

Max Drawdown

Largest peak-to-trough decline

-53.48%

-93.87%

+40.39%

Max Drawdown (1Y)

Largest decline over 1 year

-20.20%

-35.66%

+15.46%

Max Drawdown (3Y)

Largest decline over 3 years

-46.80%

Max Drawdown (5Y)

Largest decline over 5 years

-55.36%

Current Drawdown

Current decline from peak

-5.08%

-5.53%

+0.45%

Average Drawdown

Average peak-to-trough decline

-17.26%

-68.43%

+51.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.79%

13.69%

-5.90%

Volatility

DNTH vs. LQDA - Volatility Comparison

Dianthus Therapeutics Inc. (DNTH) and Liquidia Corporation (LQDA) have volatilities of 18.40% and 19.04%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DNTHLQDADifference

Volatility (1M)

Calculated over the trailing 1-month period

18.40%

19.04%

-0.64%

Volatility (6M)

Calculated over the trailing 6-month period

45.89%

48.97%

-3.08%

Volatility (1Y)

Calculated over the trailing 1-year period

66.42%

66.53%

-0.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.88%

74.06%

+2.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

76.88%

85.46%

-8.58%

Dividends

DNTH vs. LQDA - Dividend Comparison

Neither DNTH nor LQDA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DNTH vs. LQDA - Financials Comparison

This section allows you to compare key financial metrics between Dianthus Therapeutics Inc. and Liquidia Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


DNTH and LQDA have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LQDA has higher volatility (19.04%) compared to DNTH (18.40%). In terms of maximum drawdown, DNTH dropped -53.48% vs LQDA's -93.87%.

DNTH currently has the higher Sharpe Ratio (6.33 vs 5.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DNTH and LQDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer